MANF and Stroke: Using the same approach of expressing the MANF transgene in the peri-infarct region in the rat dMCAo model (Matlik et al., 2018), we conducted multiomics to study the effects of peri-infarct-targeted AAV1-MANF administration 2 days post-stroke (Teppo et al., 2020).